Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Thumbnail

Heart Team consultations lead to better patient outcomes, fewer unexpected hospitalizations

When a heart team's recommendations were followed, for example, the authors noted a “significant reduction” in cardiac mortality.

New risk score predicts mortality after TEER

Researchers developed the new algorithm by identifying eight key factors associated with mortality among TEER patients. 

Polymer-free amphilimus-eluting stents comparable to drug-eluting stents—and offer a potential advantage

The team's evaluation included data from four different randomized controlled trials

quality excellence star stethoscope

Enrollment in ACC NCDR increased after U.S. News and World Report said it could improve hospital rankings

Even with this bump, only about one in three eligible hospitals participate in the NCDR registries. 

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Implantable atrial shunt therapy trial identifies treatable HFpEF patients

The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.

Continued anticoagulation after primary PCI boosts survival among STEMI patients

A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change. 

IVUS guidance during DES implantation boosts long-term outcomes

Researchers focused on data from two previous trials to track the impact of IVUS guidance on mortality rates and other key outcomes after three years. 

Medtronic recalls a second directional atherectomy device due to risk of tip damage

There have been no incidents at this time, but the device is similar to another Medtronic solution that was recently recalled. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.